Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × tipifarnib × Clear all

NCT00005848 2013-07-11

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms